Blanka Kubešová

530 total citations
6 papers, 257 citations indexed

About

Blanka Kubešová is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Blanka Kubešová has authored 6 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Blanka Kubešová's work include Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Blanka Kubešová is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Blanka Kubešová collaborates with scholars based in Czechia, Austria and Belgium. Blanka Kubešová's co-authors include Bettina Gisslinger, Heinz Gisslinger, Róbert Královics, Mario Cazzola, Harini Nivarthi, Tiina Berg, Elisa Rumi, Roland Jäger, Christoph Bock and Stefan N. Constantinescu and has published in prestigious journals such as Blood, BMC Bioinformatics and Leukemia.

In The Last Decade

Blanka Kubešová

6 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blanka Kubešová Czechia	3	245	191	142	88	12	6	257
Klaudia Bagienski Austria	4	319 1.3×	268 1.4×	200 1.4×	115 1.3×	15 1.3×	7	365
Lingsha Zhou United States	12	377 1.5×	344 1.8×	214 1.5×	138 1.6×	16 1.3×	34	424
C Mannarelli Italy	3	240 1.0×	213 1.1×	157 1.1×	67 0.8×	4 0.3×	3	266
Olivier Mansier France	7	109 0.4×	102 0.5×	80 0.6×	51 0.6×	11 0.9×	15	164
Gaëlle Vertenoeil Belgium	4	216 0.9×	184 1.0×	136 1.0×	55 0.6×	10 0.8×	7	247
Miklós Egyed Hungary	7	156 0.6×	100 0.5×	94 0.7×	51 0.6×	8 0.7×	23	171
Tymara Berry United States	8	171 0.7×	159 0.8×	116 0.8×	57 0.6×	29 2.4×	27	233
Elisa Rumi Italy	6	428 1.7×	323 1.7×	267 1.9×	140 1.6×	8 0.7×	10	443
Pencho Georgiev Bulgaria	11	127 0.5×	230 1.2×	97 0.7×	49 0.6×	33 2.8×	30	333
Denise Wolleschak Germany	9	86 0.4×	85 0.4×	84 0.6×	35 0.4×	19 1.6×	25	157

Countries citing papers authored by Blanka Kubešová

Since Specialization

Citations

This map shows the geographic impact of Blanka Kubešová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blanka Kubešová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blanka Kubešová more than expected).

Fields of papers citing papers by Blanka Kubešová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blanka Kubešová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blanka Kubešová. The network helps show where Blanka Kubešová may publish in the future.

Co-authorship network of co-authors of Blanka Kubešová

This figure shows the co-authorship network connecting the top 25 collaborators of Blanka Kubešová. A scholar is included among the top collaborators of Blanka Kubešová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blanka Kubešová. Blanka Kubešová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Baumeister, Julian, Tiago Maié, Nicolas Chatain, et al.. (2021). Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells. Annals of Hematology. 100(12). 2943–2956. 8 indexed citations

2.

Jurček, Tomáš, et al.. (2019). A Comparison of Two Standardized Quantitative RT-PCRs with CE IVD Kit for Digital PCR in CML Patients with Different Level of BCR-ABL1 Transcripts. Blood. 134(Supplement_1). 1646–1646. 2 indexed citations

3.

Tom, Nikola, Jitka Malčíková, Šárka Pavlová, et al.. (2018). ToTem: a tool for variant calling pipeline optimization. BMC Bioinformatics. 19(1). 243–243. 1 indexed citations

4.

Kubešová, Blanka, Šárka Pavlová, Jitka Malčíková, et al.. (2017). Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status. Leukemia. 32(2). 450–461. 49 indexed citations

5.

Feenstra, Jelena D. Milosevic, Harini Nivarthi, Heinz Gisslinger, et al.. (2015). Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood. 127(3). 325–332. 196 indexed citations

6.

Feenstra, Jelena D. Milosevic, Emilie Leroy, Elisa Rumi, et al.. (2015). Whole Exome Sequencing Identifies Novel MPL and JAK2 M utations in Triple Negative Myeloproliferative Neoplasms. Blood. 126(23). 606–606. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact